/Nexus - 0404 - New Times Magazine/pages/0083/image.png)
Page Content (OCR)
66(11):2253-63. 21. Wilks, op.cit., p. 58. 22. op. cit., p. 59. 23. ibid. 24. op. cit., p. 84. 25. Grant, op. cit., p. 190. 26. Wilks, op. cit., p. 39. 27. ibid. 28. Grant, op. cit., p. 194. 29. op. cit., p. 37. 30. Beral, V., Ramchara, S., Faris, R., "Malignant melanoma and oral contraceptive use among women in California", published in The Walnut Creek Contraceptive Drug Study, NIH, vol. III, 1986, pp. 247-52. 31. Beral V., Evans, S., Shaw, H., Milton, G., "Oral contraceptive use and malignant melanoma in Australia", Br. J. Cancer (1984) 50:681-85. 32. Naish, Francesca, Natural Fertility, Sally Milner Publications, NSW, Australia, 1991. 33. Seaman, op.cit., p. 14. Endnotes 1. Archer, John, Bad Medicine, Simon & Schuster, Australia, 1995, p. 210. 2. Australian Prescription Products Guide (APPG), Minulet monograph, 1995, 24th ed., p. 1540. 3. Seaman, Barbara, The Doctors' Case Against the Pill, Hunter House, USA, 1995, p. 7. 4. ibid., p. 225. 5. The Australian Journal of Pharmacy, vol. 76, February 1995, p. 112. 6. Grant, Ellen, M.D., Sexual Chemistry, Reed Consumer Books Ltd, UK, 1994, p. 23. 7. ibid., p. 38. 8. Wilks, John, A Consumer's Guide to the Pill and Other Drugs, Freedom Publishing Company Pty Ltd, Australia, 1996, p. 16. 9. Rahwan, Prof., Contraceptives, Interceptives and Abortifacients, College of Pharmacy, Ohio State University, Ohio, USA, 1995, pp. 7. 10. Wilks, op. cit., p. 17. 11. Rahwan, op. cit., pp. 7-8. 12. Seaman, op. cit., 223. 13. ibid. 14. ibid. 15. op. cit., p. 225. 16. ibid. 17. op. cit., p. 226. 18. Chilvers, C. et al., "Oral contraceptives use and breast cancer risk in young women", The Lancet, 6 May 1989, pp. 973-982. 19. Miller, D. R., Rosenberg, L. et al., "Breast can- cer before age 45 and oral contraceptive use: new findings", American Journal of Epidemiology (1989) 129(2):269-80, Ma. 20. Romieu, I. et al., "Oral contraceptives and breast cancer: Review and meta-analysis", Cancer (1990) agenda all along was to curb women's fer- tility through the use of synthetic hormones in the hope of putting the reins on the over- population problem. Along the way, it also spawned a multi-billion-dollar industry for the pharmaceutical companies and medical researchers. One prominent clinical researcher has compared the Pill to the Vietnam War: "We got into it with the best intentions and now we don't know how the hell to get out."** The change that is needed to stop the exploitation of women's health for profit will require women as well as conscien- tious health professionals to make new, informed, safe choices. The health and well-being of millions of women world- wide and the health of future generations must no longer be sacrificed for any cause. About the Author: Sherrill Sellman runs a private psy- chotherapy practice in Melbourne. She lec- tures extensively on women's hormonal health and is also the author of the best-sell- ing book, Hormone Heresy: What Women Must Know About Their Hormones. She is a contributing writer to publications in Australia, NZ, Canada and the US. This June 1997, Sherrill is giving a series of lectures in southeast Queensland and Tasmania. For more information, contact Light Unlimited (see details on first page). Note: Part 2 will cover the Pill's links with heart disease, strokes, blood clots, nutritional deficiencies, birth defects and infertility—as well as the Pill's effect on women's psycho-spiritual health. To be continued next issue... 82 - NEXUS JUNE - JULY 1997 — A Bitter Pill to Swallow — Continued from page 29